TTM
$41.68B
YoY change
+10.9%
5Y CAGR
+18.1%
Peak year (2025)
$39.01B
Cumulative gross profit
$334.00B
Gross Profit history chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: $39.01B
Gross Profit growth chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: +10.9%
Gross Profit history table for Novo Nordisk (NVO) from 1985 to 2025
| 2025 | $39.01B | +10.9% | +$3.85B | ||
| 2024 | $35.16B | +24.0% | +$6.80B | ||
| 2023 | $28.36B | +39.0% | +$7.96B | ||
| 2022 | $20.40B | +13.3% | +$2.40B | ||
| 2021 | $18.01B | +6.0% | +$1.02B | ||
| 2020 | $16.99B | +12.5% | +$1.89B | ||
| 2019 | $15.11B | +4.9% | +$703.39M | ||
| 2018 | $14.40B | -3.2% | −$481.02M | ||
| 2017 | $14.88B | +8.6% | +$1.18B | ||
| 2016 | $13.71B | +1.8% | +$240.22M | ||
| 2015 | $13.47B | +8.1% | +$1.01B | ||
| 2014 | $12.46B | -1.7% | −$215.96M | ||
| 2013 | $12.67B | +12.8% | +$1.44B | ||
| 2012 | $11.23B | +15.4% | +$1.50B | ||
| 2011 | $9.74B | +8.9% | +$792.17M | ||
| 2010 | $8.94B | +10.9% | +$879.83M | ||
| 2009 | $8.06B | +28.1% | +$1.77B | ||
| 2008 | $6.30B | +1.0% | +$62.86M | ||
| 2007 | $6.23B | +23.5% | +$1.19B | ||
| 2006 | $5.05B | +28.9% | +$1.13B | ||
| 2005 | $3.91B | +6.0% | +$222.49M | ||
| 2004 | $3.69B | +16.5% | +$522.77M | ||
| 2003 | $3.17B | — | — | ||
| 2002 | — | — | — | ||
| 2001 | — | — | — | ||
| 2000 | — | — | — | ||
| 1999 | — | — | — | ||
| 1998 | — | — | — | ||
| 1997 | — | — | — | ||
| 1996 | — | — | — | ||
| 1995 | — | — | — | ||
| 1994 | — | — | — | ||
| 1993 | — | — | — | ||
| 1992 | — | — | — | ||
| 1991 | — | — | — | ||
| 1990 | — | — | — | ||
| 1989 | — | — | — | ||
| 1988 | — | — | — | ||
| 1987 | — | — | — | ||
| 1986 | — | — | — | ||
| 1985 | — | — | — |
- 2025$39.01B+10.9%
- 2024$35.16B+24.0%
- 2023$28.36B+39.0%
- 2022$20.40B+13.3%
- 2021$18.01B+6.0%
- 2020$16.99B+12.5%
- 2019$15.11B+4.9%
- 2018$14.40B-3.2%
- 2017$14.88B+8.6%
- 2016$13.71B+1.8%
- 2015$13.47B+8.1%
- 2014$12.46B-1.7%
- 2013$12.67B+12.8%
- 2012$11.23B+15.4%
- 2011$9.74B+8.9%
- 2010$8.94B+10.9%
- 2009$8.06B+28.1%
- 2008$6.30B+1.0%
- 2007$6.23B+23.5%
- 2006$5.05B+28.9%
- 2005$3.91B+6.0%
- 2004$3.69B+16.5%
- 2003$3.17B—
- 2002——
- 2001——
- 2000——
- 1999——
- 1998——
- 1997——
- 1996——
- 1995——
- 1994——
- 1993——
- 1992——
- 1991——
- 1990——
- 1989——
- 1988——
- 1987——
- 1986——
- 1985——
Gross Profit values are taken from Novo Nordisk's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts converted to USD using IAS 21 average exchange rates (P&L / cash flow) or closing rates (balance sheet). Originally filed in DKK.
About Gross Profit at Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's current gross profit (TTM) is $41.68B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Novo Nordisk (NVO) reported gross profit of 250.28B DKK – edged up 1.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Novo Nordisk gross profit compounded at +18.7% per year, sustaining 8 straight years of year-over-year growth.
2025 marks the peak gross profit at 250.28B DKK, with the historical low of 893.58M DKK recorded in 1986.
Novo Nordisk Gross Profit by Year
Novo Nordisk Gross Profit 2025: $39.01B
Novo Nordisk posted gross profit of 250.28B DKK ($39.01B) in 2025, edged up 1.8% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk Gross Profit 2024: $35.16B
In 2024, Novo Nordisk reported gross profit of 245.88B DKK ($35.16B), grew 25.1% from 2023.
Novo Nordisk Gross Profit 2023: $28.36B
Novo Nordisk gross profit in 2023 was 196.50B DKK ($28.36B), surged 32.3% from 2022.
Novo Nordisk Gross Profit 2022: $20.40B
2022's gross profit for Novo Nordisk came in at 148.51B DKK ($20.40B), grew 26.8% from 2021.
Novo Nordisk Gross Profit 2021: $18.01B
Novo Nordisk gross profit in 2021 was 117.14B DKK ($18.01B).
See more financial history for Novo Nordisk (NVO).
Sector peers by Gross Profit
Healthcare peers of Novo Nordisk (NVO), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $26.01B | |
| $16.78B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $26.01B
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation